Journals / Journal of the Turkish-German Gynecological Association / 2014 / Cilt: 15 - Sayı: 1

Incidence of gestational trophoblastic disease in Tokat province, Turkey

Pages
22–24
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The incidence of GTD, which has a high recovery rate with adequate treatment and follow-up, can be determined from regional and community-based research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study investigated the incidence of gestational trophoblastic disease (GTD) in Tokat province, Turkey.
📊
Key Findings & Data:Material and Methods: The medical records of patients who had been diagnosed and treated at one university hospital, six government hospi- tals, and one specialist hospital in Tokat province between January 2005 and December 2012 were evaluated retrospectively.
💡
Conclusion & Impact:The incidence of GTD, which has a high recovery rate with adequate treatment and follow-up, can be determined from regional and community-based research.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study investigated the incidence of gestational trophoblastic disease (GTD) in Tokat province, Turkey. Material and Methods: The medical records of patients who had been diagnosed and treated at one university hospital, six government hospi- tals, and one specialist hospital in Tokat province between January 2005 and December 2012 were evaluated retrospectively. Results: During the study period, there were 59,754 births and GTD was diagnosed in 73 cases. The calculated GTD incidence was 1.22/1000. The mean age of the patients diagnosed with GTD was 28.6±7.3 (range 17-51) years. In GTD, complete moles occurred in 26%, partial moles in 74%, and no invasive moles, choriocarcinomas, or placental site trophoblastic tumours were found. Only two patients received chemotherapy (methotrexate). There was no mortality associated with the disease during follow-up. Conclusion: The incidence of GTD in Tokat province was 1.2 per 1000 births. Early diagnosis, treatment, and follow-up play a critical role in preventing the morbidity and mortality associated with disease. The incidence of GTD, which has a high recovery rate with adequate treatment and follow-up, can be determined from regional and community-based research.

🔖

Cite This Article

NACAR, M. C., ÇAKMAK, B., KÖSEOĞLU, R. D., TOPRAK, M., GÜNERİ, N. (2022). Incidence of gestational trophoblastic disease in Tokat province, Turkey. Journal of the Turkish-German Gynecological Association, Cilt: 15 - Sayı: 1, 22–24. https://ajindex.com/articles/568080

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Berkowitz RS, Goldstein DP Gestational Trophoblastic Disease. In: Berek JS, Adashi EY, Hillard PA, editors. Novak’s Gynecology. Phila- delphia, USA: Mass Publishing CO. 1996.p.1261. 2.Ghaemmaghami F, Ashraf-Ganjooie T. Gestational trophoblastic neoplasia. Asia-Pacific J Clin Oncol 2006
  2. [CrossRef] 3.Ozalp SS, Yalcın OT, Tanır HM. Hidatiform mole in Turkey from 1932 to 2000. Int J Gynecol Obstet 2001
  3. [CrossRef] 4.Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemi- ology and etiology of gestational trophoblastic diseases. Lancet Oncol 2003
  4. [CrossRef] 5.Hayashi K, Bracken MB, Freeman DH Jr, Hellenbrand K. Hydatidi- form mole in United States (1970-1977): a statistical and theoretical analysis. Am J Epidemiol 1982
  5. Palmer JR. Advences in the epidemiology of gestational tropho- blastic disease. J Reprod Med 1994
  6. Harma M, Harma M, Yurtseven S, Gungen N. Gestational tro- phoblastic disease in Sanliurfa, southeast Anatolia, Turkey. Eur J Gyneacol Oncol 2005
  7. Kurdoğlu M, Kurdoğlu Z, Küçükaydın Z, Şahin GHG, Kamacı M. Gestational trophoblastic diseases: Fourteen year experience of our clinic. J Turk Soc Obstet Gynecol 2011
  8. [CrossRef] 9.Oguz S, Karakoca GA, Aydoğdu T, Gökmen O. Clinical analysis of 165 gestational trophoblastic disease cases. T Klin Jinekol Obst 2002
  9. Gezginç K, Görkemli H, Çelik Ç, Acar A, Çolakoğlu C, Akyürek C. Kliniğimizdeki gestasyonel trofoblastik hastalıklı vakaların analizi. Türk Jinekolojik Onkoloji Dergisi 2004
  10. Yumru AE, Dinçgez B, Ondeş B, Bozyiğit A. Epidemiologic charac- teristics and management of subjects who were diagnosed with trophoblastic disease. Erciyes Med J 2012
  11. [CrossRef] 12.Ozalp S, Metintaş S, Arslantaş D, Işikli B, Kalyoncu C. Frequency of hydatidiform mole in the rural part of Eskişehir, Turkey. Eur J Gynaecol Oncol 2003
  12. Çetin M, Balta Ö, Duran B, Güvenal T, Yanar O. A retrospective study of molar pregnancy cases submitted to our clinic. CÜ Tıp Fakültesi Dergisi 2004
  13. Malatyalıoğlu E. Clinical evaluation of 19 gestational trophoblastic neoplasms. Ondokuz Mayıs Üni Tıp Fak Derg 1990
  14. Matsui H, Iitsuka Y, Suzuka K, Seki K, Sekiya S. Subsequent preg- nancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between com- plete and partial mole. Hum Reprod 2001
  15. [CrossRef] 16.Lurain